A detailed history of Dunhill Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Dunhill Financial, LLC holds 3,142 shares of JNJ stock, worth $488,581. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,142
Previous 2,815 11.62%
Holding current value
$488,581
Previous $411 Million 23.77%
% of portfolio
0.26%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$145.48 - $167.38 $47,571 - $54,733
327 Added 11.62%
3,142 $509 Million
Q2 2024

Aug 09, 2024

BUY
$144.38 - $157.78 $208,484 - $227,834
1,444 Added 105.32%
2,815 $411 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $5,898 - $6,184
38 Added 2.85%
1,371 $217 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $194,084 - $211,787
1,333 New
1,333 $209 Million
Q2 2023

Aug 23, 2023

BUY
$154.35 - $166.11 $233,068 - $250,826
1,510 New
1,510 $252 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.